Premium
Prescribing practices for antibiotic prophylaxis in patients with prosthetic joints
Author(s) -
Teixeira Erica C.,
Warren John J.,
McKernan Susan C.,
McQuistan Michelle R.,
Qian Fang
Publication year - 2020
Publication title -
special care in dentistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.328
H-Index - 41
eISSN - 1754-4505
pISSN - 0275-1879
DOI - 10.1111/scd.12450
Subject(s) - medicine , antibiotic prophylaxis , antibiotics , intensive care medicine , family medicine , microbiology and biotechnology , biology
Abstract Aims With the increasing number of patients with prosthetic joints, recommendations for antibiotic prophylaxis (AP) prior to dental procedures to prevent prosthetic joint infections (PJI) have changed. Methods and results This survey evaluated dentists’ AP practices for patients with prosthetic joints undergoing dental procedures and their familiarity with the American Dental Association Guidelines (ADA CPG) and American Academy of Orthopaedic Surgeons Appropriate Use Criteria (AAOS AUC). Dentists’ attitudes about antibiotic resistance, medical‐legal aspects, and adverse effects to using AP were examined. Dentists ( n = 574) were familiar (51.2%) with ADA CPG and with the AAOS AUC (25.8%). Familiarity varied according to years since graduation. Female dentists (63.5%) were more likely to be very familiar with the ADA CPG than male dentists (49.5%). Overall, 65.4% of respondents believed that AP is not effective in the prevention of PJI, and 19.4% believed there is enough evidence to support AP. For a healthy patient, 28.9% of dentists would never recommend AP, 44.9% would recommend AP within the first two years since prosthetic joint replacement. Conclusions Dentists’ recommendations for the use of AP varied depending on different factors, including health status of the patient, dental procedure, time elapsed since joint surgery, suggesting that adherence to the ADA CPG and AUC is still challenging.